Medicine and Dentistry
Surgical Anastomosis
100%
Krukenberg Tumor
50%
Immunohistochemistry
50%
Neoplasm
50%
Metastatic Carcinoma
50%
Pancreaticojejunostomy
50%
Pancreas Fistula
50%
Pancreaticoduodenectomy
50%
Lower Anterior Resection
50%
Urinary System
50%
Rectum Cancer
50%
Open Surgery
50%
Gastrectomy
50%
Tensin
50%
Colon Tumor
33%
Laparoscopy
29%
Pelvis
25%
Robot-Assisted Surgery
25%
Arm
18%
Neoadjuvant Chemotherapy
16%
Differential Diagnosis
16%
Colorectal Tumor
16%
Female Genital Tract Cancer
16%
Carboplatin
16%
Colon
16%
Colonoscopy
16%
Paclitaxel
16%
Magnetic Resonance Imaging
16%
Cytoreductive Surgery
16%
Mesentery
16%
CA-125
16%
Primary Peritoneal Carcinoma
16%
Pelvic Floor
16%
Rectal Bleeding
16%
Diagnosis
16%
Parenchyma
16%
Debulking Surgery
16%
Final Diagnosis
16%
Sigmoid
16%
Ileorectal Anastomosis
16%
Tumor Marker
16%
Adenocarcinoma
16%
Recurrent Disease
12%
Melena
12%
Bleeding
12%
Operation Duration
12%
Bladder Cancer
12%
Cystectomy
12%
Injury
12%
Peritoneum Adhesion
12%
Indocyanine Green
12%
End to End Anastomosis
6%
Clinical Stage
6%
Stomach Cancer
6%
Postoperative Complication
6%
Billroth I
6%
Tyrosine Kinase Receptor
5%
Keyphrases
Deloyers Procedure
50%
Urinary Reservoirs
50%
Minimally Invasive Pancreaticoduodenectomy
50%
Robot-assisted Distal Gastrectomy
50%
Totally Robotic
50%
Stem Cell Factor
50%
Pancreatic Cancer Cells
50%
C-kit
50%
Powered Stapler
25%
Surgical Assistant
25%
Imatinib Mesylate
22%
Pancreatic Cancer Cell Lines
22%
Primary Colorectal Cancer
20%
Excretory Dysfunction
16%
Postoperative Bowel Function
16%
Tumor Marker CA125
16%
Cecal Resection
16%
Green's Function
12%
Bladder Resection
12%
Pelvic Adhesions
12%
Reservoir Complications
12%
Pelvic Space
12%
Functional End-to-end Anastomosis
12%
Gastric Conduit Reconstruction
12%
Reconstruction Technique
12%
Billroth I Anastomosis
12%
Duodenal Stump
12%
Immunohistochemistry
11%
Pancreatic Cancer
11%
Chronic Myeloid Leukemia
11%
Gastrointestinal Stromal Tumor
11%
BxPC-3
5%
Clinical Specimens
5%
Therapeutic Target
5%
Transmembrane Protein
5%
Hematological Malignancies
5%
Cell Proliferation
5%
Cancer Invasion
5%
Invasiveness
5%
Induced Proliferation
5%
Tumor Malignancy
5%
Clinical Features
5%
Capan-2
5%
Invasive Ability
5%
MIA PaCa-2
5%
Receptor Tyrosine Kinase
5%
Tyrosine Kinase Receptor
5%
SW1990
5%
Solid Tumors
5%
Venous System
5%
Small Cell Lung Cancer
5%
Western Blot Analysis
5%
Pancreatic Cancer Tissue
5%
Inhibitory Effect
5%
Cell Differentiation
5%
PANC-1
5%
Cancer Cell Proliferation
5%
Immunohistochemical Method
5%
Quantitative PCR
5%